CD34 and cervical carcinoma: Divided by different immunohistochemical biomarkers among the subgroups, “anti-factor VIII” antibody (HR = 1.60, 95% CIs 1.16–2.03, I2 = 0, n = 3) showed the significantly negative association between MVD and DFS among cervical cancer patients, but not in “CD34” subgroup (HR = 1.23, 95% CIs 0.71–1.75, I2 = 8.4%, n = 2).